Cite
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
MLA
Szabo, Gyongyi, et al. “IL-1 Receptor Antagonist plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis.” Hepatology (Baltimore, Md.), vol. 76, no. 4, Oct. 2022, pp. 1058–68. EBSCOhost, https://doi.org/10.1002/hep.32478.
APA
Szabo, G., Mitchell, M., McClain, C. J., Dasarathy, S., Barton, B., McCullough, A. J., Nagy, L. E., Kroll-Desrosiers, A., Tornai, D., Min, H. A., Radaeva, S., Holbein, M. E. B., Casey, L., & Cuthbert, J. (2022). IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology (Baltimore, Md.), 76(4), 1058–1068. https://doi.org/10.1002/hep.32478
Chicago
Szabo, Gyongyi, Mack Mitchell, Craig J McClain, Srinivasan Dasarathy, Bruce Barton, Arthur J McCullough, Laura E Nagy, et al. 2022. “IL-1 Receptor Antagonist plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis.” Hepatology (Baltimore, Md.) 76 (4): 1058–68. doi:10.1002/hep.32478.